StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.45−1.09 (-3.82%)

Close on Nov 17, 2026Market cap $1.33BP/E –Yield –

Nanobiotix enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Nanobiotix's enterprise value was $1.58T on Nov 11, 2026, against $977.88B a year earlier. Over the last 5 years it ranged from $74.54B to $1.94T, with a median of $215.58B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.58T+44.2%
2025Dec 31, 2025$1.09T+931.7%
2024Dec 31, 2024$105.92B-58.3%
2023Dec 29, 2023$253.70B+99.1%
2022Dec 30, 2022$127.40B-35.5%
2021Dec 31, 2021$197.41B-44.7%
2020Dec 31, 2020$356.88B–

More Nanobiotix figures

See a number that looks wrong?